Strategic Forecast 2026: Navigating the Global Mefenamic Acid Market
As of early 2026, the global mefenamic acid market continues to hold a resilient position within the non-steroidal anti-inflammatory drug (NSAID) sector. While newer analgesics often dominate the North American landscape, mefenamic acid—an anthranilic acid derivative—remains a cornerstone of pain … Read more